Freestone Capital Holdings’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,000	Closed	-$277K	–	585
2021 Q4	$277K	Buy	+20,000	New	+$277K	0.01%	423
2021 Q1	–	Sell	-2,000	Closed	-$14.9K	–	458
2020 Q4	$14.9K	Hold	2,000	–	–	﹤0.01%	775
2020 Q3	$6.87K	Buy	+2,000	New	+$6.87K	﹤0.01%	815